Application 203883

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	ADENOSINE	ADENOSINE	SOLUTION;INTRAVENOUS	60MG/20ML (3MG/ML)	No	No
002	ADENOSINE	ADENOSINE	SOLUTION;INTRAVENOUS	90MG/30ML (3MG/ML)	No	No

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
0409-1932	Adenosine	ADENOSINE	Hospira, Inc.	ANDA	Current
0409-1932	Adenosine	ADENOSINE	Hospira, Inc.	ANDA	Current
0409-1932	Adenosine	ADENOSINE	Hospira, Inc.	ANDA	Current
0409-1932	Adenosine	ADENOSINE	Hospira, Inc.	ANDA	Current
51662-1345	ADENOSINE	ADENOSINE	HF Acquisition Co LLC, DBA HealthFirst	ANDA	Current
51662-1345	ADENOSINE	ADENOSINE	HF Acquisition Co LLC, DBA HealthFirst	ANDA	Current
51662-1345	ADENOSINE	ADENOSINE	HF Acquisition Co LLC, DBA HealthFirst	ANDA	Current
51662-1345	ADENOSINE	ADENOSINE	HF Acquisition Co LLC, DBA HealthFirst	ANDA	Current